GIA announces the release of a comprehensive global report on Bone and Joint Health Supplements market. The global market for bone and joint health supplements is forecast to reach $9.09 billion by the year 2017, supported by increasing number of aging population and age-related problems such as osteoporosis, calcium loss, osteoarthritis, bone fractures and other bone and joint diseases. Spiraling healthcare costs, hectic lifestyles and the desire to lead a longer, active and healthier life is prompting both the young and old consumers to shift from a reactive to proactive style of living. The growing focus on healthy eating habits, diet and nutritional fortification is driving the bone and joint health supplements market. Developing markets led by Asia-Pacific will take the growth forward, particularly for calcium, glucosamine, vitamins, soy isoflavones and other supplements.
San Jose, California (PRWEB) August 25, 2011
Development of supplements is likely to increase in future, with marketers capitalizing on the aging population world over. Fish oils, herbal supplements and other natural offerings such as probiotic acidohiplus and detoxes are emerging as alternatives to conventional synthetic supplements. People of different age groups are turning to natural health supplements as they offer greater health benefits in comparison to artificial supplements. Food supplements, including omega-3s, herbal extracts, multivitamins, probiotics, chondroitin and glucosamine logged healthy growth rates in 2008 and 2009 despite the economic downturn and squeeze in consumer spending.
The market for general dietary supplements is losing sheen, while the demand for specialty supplements is growing at a heady pace, since specialty products are scientifically proven, efficient and primarily aimed at self-help oriented customers. Vegetable-sourced glucosamine is the latest trend prevalent in the bone and joint health market. Manufacturers are increasingly using vegetarian ingredients for catering to the needs of the growing ‘green’ and vegetarian population. Since glucosamine is derived from shellfish and other animal sources, the trend is gaining popularity not just with vegetarians, but also with people allergic to shellfish and those following a kosher diet. Combination supplements are also growing in importance, as they are perceived to offer higher clinical efficacy compared to a single/stand-alone ingredient. Glucosamine, earlier used independently to repair and rebuild human cartilage, is now increasingly paired with other ingredients, most notably Chondroitin, that promotes more elastic cartilage.
The US market, driven by aging baby boomers represents the single largest market, as stated by the new research report on Bone and Joint Health Supplements. Growing incidence of obesity, sports injuries and consumer awareness is driving the demand for joint health supplements/ingredients, including glucosamine in the US market. Japan trails closely as the other important market, propelled by market deregulation, health care expenditure, stress on healthy diets and rapidly aging population. Asia-Pacific, largely spurred by China, the largest producer and supplier of glucosamine globally, is forecast to surge ahead at the overall fastest CAGR of 6.8% through 2017. Calcium Supplements account for a dominant share of the bone and joint supplements market. The category for other supplements such as vitamin D, vitamin K2, MSM, soy isoflavones, collagen and others is poised to expand at a robust pace of 6.0% over the analysis period.
Key market participants profiled in the report include, Archer Daniel Midland Company, Bergstrom Nutrition, Inc, Cargill, Inc., DSM Nutritional Products Ltd, Danisco A/S, ESM Technologies LLC, Ethical Naturals, Inc, Kappa Bioscience AS, Koyo Chemical Company Ltd., Navamedic ASA, NBTY, Inc, Schiff Nutrition International, Inc, Simply Supplements, Zhejiang Freeman Shinfuda Co. Ltd., among several others.
The research report titled “Bone and Joint Health Supplements: A Global Strategic Business Report” announced by Global Industry Analysts, Inc., provides a comprehensive review of industry, segment and product overview, trends & issues, herbal supplements, recent industry activity and profiles of market players worldwide. Market analytics and overview is provided in value (US$) terms for major geographic markets such as US, Japan, Europe, Asia-Pacific and Rest of World. Major product segments analyzed include, Glucosamine-Chondroitin Supplements, Calcium Supplements and Other Supplements. The study also provides historic data for an insight into market evolution over the period 2003 through 2008.
For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Bone_and_Joint_Health_Supplements_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/
###
Public Relations
Global Industry Analysts, Inc.
(408) 528-9966
Email Information
There are no comments yet